Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00326781 · ClinicalTrials.gov registry record · Phase 4
Bio-Behavioral Predictors of the Efficacy of Nicotine Replacement Therapy (NRT)
A Phase 4 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 4
- Development phase
- 674
- Enrollment target
NCT00326781: Completed Phase 4 study, sponsored by University of Pennsylvania.
NCT00326781 is a Phase 4 study that has completed, run by University of Pennsylvania. The registered enrollment target is 674 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00326781, a Phase 4 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 674 participants
- Enrollment target
Study Summary
The purpose of this research study is to: 1. compare the effectiveness of a nicotine patch and nicotine nasal spray for smoking cessation; and 2. identify predictors of response to these alternate forms of nicotine replacement therapy (NRT).
Interventions
- DRUG Nicotine Nasal Spray
- DRUG Nicoderm Transdermal Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 674 participants |
| Start Date | 1999-12 |
| Est. Completion | 2004-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00326781
The ClinicalTrials.gov registry entry for NCT00326781 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 674 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nicotine Nasal Spray is the first listed.
NCT00326781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00326781 about?
NCT00326781 is a clinical study titled "Bio-Behavioral Predictors of the Efficacy of Nicotine Replacement Therapy (NRT)". The purpose of this research study is to: 1. compare the effectiveness of a nicotine patch and nicotine nasal spray for smoking cessation; and 2. identify predictors of response to these alternate forms of nicotine replacement therapy (NRT).
What is the current status of trial NCT00326781?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 674 participants. The study started on 1999-12. Estimated completion is 2004-08.
What interventions are being tested in trial NCT00326781?
The interventions under investigation include: Nicotine Nasal Spray (DRUG), Nicoderm Transdermal Patch (DRUG).
Who is sponsoring clinical trial NCT00326781?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.